Tosi-Bosan B2-Liq 5 D Liquid is a Health Canada–registered human drug (DIN 02157853) held by Professional Health Products, containing Phosphorus. Health Canada lists its status as Cancelled Post Market (status date 10 Jul 2006). Nexara Health has matched 34 registrations of Phosphorus across 7 other regulated markets, 7 of them in the same strength and dosage form.
Health Canada registration
| DIN | 02157853 |
|---|---|
| Brand name | Tosi-Bosan B2-Liq |
| Active ingredient | Phosphorus |
| Strength | 5 D |
| Dosage form | Liquid |
| Route | Oral |
| Company | Professional Health Products |
| Status | Cancelled Post Market — 10 Jul 2006 |
| Class | Human |
| ATC | |
| AHFS | 92:02.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Phosphorus registered in other markets
34 registrations of the same molecule in 7 national registries outside Canada (first 19 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| United States | Phosphorus | Rxhomeo Private Limited d.b.a. Rxhomeo, Inc | Liquid | listed | FDA NDC | |
| United States | Phosphorus | Energique, Inc. | Liquid | listed | FDA NDC | |
| United States | Phosphorus | Herbamed AG | Liquid | FDA NDC | ||
| United States | Phosphorus 30 | Uriel Pharmacy Inc. | Liquid | listed | FDA NDC | |
| United States | Phosphorus 30X | True Botanica, LLC | Liquid | listed | FDA NDC | |
| United States | Phosphorus 7130 | Professional Complementary Health Formulas | Liquid | listed | FDA NDC | |
| United States | Phosphorus 8 | Uriel Pharmacy Inc. | Liquid | listed | FDA NDC | |
| Australia | Phosphate Phebra | Fg | Tablet, compound effervescent, equivalent to 500 mg phosphorus | GE | PBS | |
| Australia | Phosphate Phebra | Fg | Tablet, compound effervescent, equivalent to 500 mg phosphorus | GE | PBS | |
| Czech Republic | Phosphorus | — | 3CH-30CH | Gra | R | SUKL DLP |
| Finland | Phosphorus | Circlum Farmasia Oy | C6, C12, C30, C200, M, XM | pilleri | Rekisteröinti myönnetty | Fimea Perusrekisteri |
| Finland | Phosphorus | DCG Nordic AB | D6,D12,D30,D200,M,CM | pilleri | Rekisteröinti myönnetty | Fimea Perusrekisteri |
| Netherlands | Phosphorus | BOIRON (Messimy) | 6 DH t/m 60 DH#3CH t/m 200 CH#6 K t/m 100.000 K#2 LM t/m 30 LM | Uitsluitend apotheek of drogist | EU national register | |
| Netherlands | Phosphorus | BOIRON (Messimy) | 6 DH t/m 60 DH#3 CH t/m 200 CH#6 K t/m 100.000 K#2 LM t/m 30 LM | Globuli | Uitsluitend apotheek of drogist | EU national register |
| United Arab Emirates | Phosphorus Boiron | BOIRON, France, Messimy | 4 DH - 200 CH | Pillules | Active | EDE |
| United Kingdom | Phosphorus 30c homeopathic pillules | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Phosphorus 30c homeopathic tablets | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Phosphorus 6c homeopathic tablets | — | 0001 | NHS dm+d VMP | ||
| United States | Bestmade Natural Products Phosphorus | Bestmade Natural Products | Tablet, Soluble | listed | FDA NDC |
See every manufacturer of Phosphorus worldwide →
Regulator price references for Phosphorus
Published list or reimbursement prices for Phosphorus presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Australia | Phosphate Phebra | Tablet, compound effervescent, equivalent to 500 mg phosphorus | 63.59 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Phosphate Phebra | Tablet, compound effervescent, equivalent to 500 mg phosphorus | 63.59 AUD | ex-manufacturer | PBS | 2026-09-08 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Tosi-Bosan B2-Liq (DIN 02157853) marketed in Canada?
No. Health Canada lists DIN 02157853 as Cancelled Post Market as of 10 Jul 2006.
Who holds the Canadian licence for this product?
Professional Health Products is the company of record in the Health Canada Drug Product Database.
Is Phosphorus registered outside Canada?
Yes — Nexara Health has matched 34 registrations in 7 other markets, including 7 in the same strength and dosage form (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02157853, status date 2006-07-10; national medicine registries: EDE, EU national register, FDA NDC, Fimea Perusrekisteri, NHS dm+d VMP, PBS, SUKL DLP; price sources: PBS. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02157853, status date 2006-07-10; national medicine registries: EDE, EU national register, FDA NDC, Fimea Perusrekisteri, NHS dm+d VMP, PBS, SUKL DLP; price sources: PBS.
Health Canada Drug Product Database (DPD), DIN 02157853, status date 2006-07-10; national medicine registries: EDE, EU national register, FDA NDC, Fimea Perusrekisteri, NHS dm+d VMP, PBS, SUKL DLP; price sources: PBS. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.